Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 18.82 Million USD | 879.32% |
| 2022 | 1.92 Million USD | -59.13% |
| 2021 | 4.7 Million USD | 36.9% |
| 2020 | 3.43 Million USD | 65.1% |
| 2019 | 2.08 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 1.66 Million USD | -13.63% |
| 2023 FY | 18.82 Million USD | 879.32% |
| 2023 Q4 | 18.82 Million USD | 232.81% |
| 2023 Q3 | 5.65 Million USD | 182.8% |
| 2023 Q2 | 1.99 Million USD | 20.47% |
| 2022 Q3 | 2.08 Million USD | -45.13% |
| 2022 Q4 | 1.92 Million USD | -7.75% |
| 2022 FY | 1.92 Million USD | -59.13% |
| 2022 Q1 | 4.86 Million USD | 3.49% |
| 2022 Q2 | 3.79 Million USD | -21.99% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 4.7 Million USD | 36.9% |
| 2021 Q4 | 4.7 Million USD | 33.04% |
| 2021 Q3 | 3.53 Million USD | 0.0% |
| 2020 FY | 3.43 Million USD | 65.1% |
| 2020 Q4 | 3.43 Million USD | 0.0% |
| 2019 FY | 2.08 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | 98.014% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | -104.667% |
| Embecta Corp. | 2.03 Billion USD | 99.076% |
| Pacira BioSciences, Inc. | 704.25 Million USD | 97.327% |
| PainReform Ltd. | 2.69 Million USD | -599.458% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -206.574% |
| SCYNEXIS, Inc. | 55.45 Million USD | 66.055% |
| Journey Medical Corporation | 56.49 Million USD | 66.685% |
| Safety Shot Inc | 3.89 Million USD | -383.612% |
| Alpha Teknova, Inc. | 38.55 Million USD | 51.175% |
| Bright Green Corporation | 6.43 Million USD | -192.36% |
| Procaps Group, S.A. | 462.06 Million USD | 95.926% |
| Alvotech | 1.88 Billion USD | 99.0% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | 96.009% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | 88.516% |
| Cosmos Health Inc. | 30.25 Million USD | 37.782% |
| Dynavax Technologies Corporation | 375.02 Million USD | 94.981% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | 97.152% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | 86.248% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -206.574% |
| Theratechnologies Inc. | 98.63 Million USD | 80.918% |
| Harrow Health, Inc. | 241.75 Million USD | 92.214% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | -114.966% |
| Biofrontera Inc. | 23.13 Million USD | 18.655% |
| DURECT Corporation | 30.4 Million USD | 38.096% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | 96.139% |
| Cronos Group Inc. | 43.73 Million USD | 56.964% |
| OptiNose, Inc. | 194.33 Million USD | 90.314% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | 97.697% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | 61.147% |
| RedHill Biopharma Ltd. | 20.97 Million USD | 10.276% |
| Organogenesis Holdings Inc. | 181.36 Million USD | 89.622% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -398.986% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | 64.159% |
| Radius Health, Inc. | 804.29 Million USD | 97.66% |
| Universe Pharmaceuticals INC | 13.75 Million USD | -36.847% |
| ProPhase Labs, Inc. | 42.54 Million USD | 55.758% |
| Phibro Animal Health Corporation | 725.54 Million USD | 97.406% |
| Procaps Group S.A. | 462.06 Million USD | 95.926% |
| TherapeuticsMD, Inc. | 14.02 Million USD | -34.235% |
| Viatris Inc. | 27.21 Billion USD | 99.931% |
| Rockwell Medical, Inc. | 30.88 Million USD | 39.051% |
| Aytu BioPharma, Inc. | 90.37 Million USD | 79.174% |
| SIGA Technologies, Inc. | 57.97 Million USD | 67.535% |
| Tilray Brands, Inc. | 892.11 Million USD | 97.89% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | 91.437% |
| Shineco, Inc. | 47.6 Million USD | 60.459% |
| PetIQ, Inc. | 645.22 Million USD | 97.083% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -8474.659% |
| Incannex Healthcare Limited | 5.83 Million USD | -222.854% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | 98.154% |
| Alimera Sciences, Inc. | 107.35 Million USD | 82.467% |
| Silver Spike Investment Corp. | 3 Million USD | -525.364% |
| Assertio Holdings, Inc. | 148.41 Million USD | 87.318% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -892.761% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | 11.697% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | -167.896% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -121.687% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | 89.144% |
| Talphera, Inc. | 6.29 Million USD | -199.243% |
| Alvotech | 1.88 Billion USD | 99.0% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | 89.095% |
| Lantheus Holdings, Inc. | 835.25 Million USD | 97.747% |
| Currenc Group, Inc. | 177.67 Million USD | 89.406% |
| Kamada Ltd. | 109.96 Million USD | 82.884% |
| Indivior PLC | 1.95 Billion USD | 99.035% |
| Evoke Pharma, Inc. | 9.64 Million USD | -95.09% |
| Flora Growth Corp. | 17.22 Million USD | -9.293% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -121.687% |
| Evolus, Inc. | 209.68 Million USD | 91.024% |
| HUTCHMED (China) Limited | 536.38 Million USD | 96.491% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | 97.845% |
| Akanda Corp. | 12.66 Million USD | -48.572% |